首页> 外文OA文献 >PND26 COST-UTILITY OF INTERFERON BETA-1B IN THE TREATMENT OF PATIENTS WITH A CLINICALLY ISOLATED SYNDROME SUGGESTIVE OF MULTIPLE SCLEROSIS IN SPAIN

【2h】

PND26 COST-UTILITY OF INTERFERON BETA-1B IN THE TREATMENT OF PATIENTS WITH A CLINICALLY ISOLATED SYNDROME SUGGESTIVE OF MULTIPLE SCLEROSIS IN SPAIN

机译：PND26干扰素BETA-1B在西班牙多发性硬化症临床隔离综合征患者中的治疗效用

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Arbizu T; Piñol C; Casado V;
展开▼
作者单位

展开▼
年度 2009
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Cost-Effectiveness Analysis of Interferon Beta-1b for the Treatment of Patients With a First Clinical Event Suggestive of Multiple Sclerosis [J] . CaloyerasJ.P., ZhangB., WangC., Clinical therapeutics . 2012,第5期

机译：干扰素β-1b治疗首例提示多发性硬化的临床事件的成本效果分析
2. COST-UTILITY ANA LYSIS OF INTRAMUSCULAR INTERFERON BETA-1B VERSUS SUBCUTANEOUS INTERFERON BETA-1B AND BETA-1A IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN COLOMBIA [J] . Ordonez J., Delgado A. Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2016,第3期

机译：哥伦比亚缓解性多发性硬化症患者的肌内干扰素BETA-1B与皮下干扰素BETA-1B和BETA-1A的成本效用分析
3. Good results for early treatment of clinically isolated syndrome prior to multiple sclerosis with interferon beta-1b and glatiramer group. [J] . Doggrell SA Expert opinion on pharmacotherapy . 2010,第7期

机译：在干扰素β-1b和格拉替雷组治疗多发性硬化之前，临床分离综合征的早期治疗效果良好。
4. Prognostic Value of Brain Tissue Pathological Changes in Patients with Clinically Isolated Syndromes (CIS) Suggestive of Multiple Sclerosis Using Magnetization Transfer Ratio (MTR) [C] . Fooladi, M., Alam, Engineering in Medicine and Biology Society, 2007 Annual International Conference of the IEEE . 2007

机译：磁化转移率（MTR）提示多发性硬化的临床孤立综合征（CIS）患者脑组织病理学改变的预后价值
5. Impacto clínico y Coste-Utilidad Del Tratamiento De La Osteoporosis En Espa?a =Clinical impact and cost-utility of the osteoporosis treatment in Spain [D] . Osca Guadalajarara, Marta. 2021

机译：西班牙骨质疏松症治疗的临床影响及成本效用=西班牙骨质疏松症治疗的临床影响及成本效用
6. Evidence for the efficacy of interferon beta-1b in delaying the onset of clinically definite multiple sclerosis in individuals with clinically isolated syndrome [O] . Mark S. Freedman 2014

机译：干扰素β-1b延缓临床孤立综合征患者临床明确的多发性硬化症发作的功效的证据
7. ND4 COST-UTILITY OF INTERFERON BETA-1B IN THE TREATMENT OF PATIENTS WITH A CLINICALLY ISOLATED SYNDROME SUGGESTIVE OF MULTIPLE SCLEROSIS: MODEL UTILIZING FIVE YEAR BENEFIT DATA [O] . Caloyeras JP, Harrow B, Wang C, 2009

机译：干扰素BETA-1B在多发性硬化症临床隔离综合征患者中的成本效用：利用五年受益数据的模型

PND26 COST-UTILITY OF INTERFERON BETA-1B IN THE TREATMENT OF PATIENTS WITH A CLINICALLY ISOLATED SYNDROME SUGGESTIVE OF MULTIPLE SCLEROSIS IN SPAIN

著录项

引文网络

相似文献

相关主题

期刊订阅